![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://finance.yahoo.com/news/entasis-therapeutics-announces-positive-topline-200500307.html
https://www.prnewswire.com/news-releases/everest-medicines-announces-approval-of-investigational-new-drug-application-by-china-nmpa-for-spr206-301384591.html
https://www.fiercebiotech.com/research/arming-antibiotics-a-vaccination-like-immune-response
https://www.biospectrumasia.com/news/25/10449/micurx-to-receive-funds-from-carb-x-for-innovative-antibiotic.html
http://www.forbes.com/sites/henrymiller/2016/12/02/to-fight-the-antibiotic-resistance-scourge-the-senate-must-pass-the-21st-century-cures-act/#6c1088963449
http://www.reuters.com/article/us-health-antibiotics-europe-idUSKCN0UP1QK20160111
https://www.newscientist.com/article/dn28633-resistance-to-last-resort-antibiotic-has-now-spread-across-globe/
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/new-drug-effective-against-antibiotic-resistant-superbugs/articleshow/45455046.cms